![Tobin Juvenal](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tobin Juvenal
Corporate Officer/Principal bei CASTLE BIOSCIENCES, INC.
Vermögen: 1 Mio $ am 31.05.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Derek Maetzold | M | 62 | 17 Jahre | |
Daniel Bradbury | M | 62 | 12 Jahre | |
G. Cole | M | 68 | 6 Jahre | |
Tiffany Olson | F | 64 | 3 Jahre | |
Kristen Oelschlager | F | 56 | 16 Jahre | |
Kimberlee Caple | F | 62 | 3 Jahre | |
Robert W. Cook | M | 52 | 13 Jahre | |
Ellen Goldberg | F | 50 | 3 Jahre | |
Miles Harrison | M | 59 | 4 Jahre | |
Camilla Zuckero | F | - | 5 Jahre | |
John Abbott | M | - | 10 Jahre | |
Kevin Doman | M | - | 2 Jahre | |
Chris Otte | M | - | - | |
Keli Greenberg | F | - | 4 Jahre | |
John C. Cheneval | M | - | 3 Jahre | |
Noreen Manning | F | - | - | |
Matthew Goldberg | M | - | 4 Jahre | |
Alice Bahner Izzo | F | - | 11 Jahre | |
Franklin Stokes | M | 54 | 7 Jahre | |
Johnson Clare | M | - | 3 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
George Cole | M | 75 |
Encysive Pharmaceuticals, Inc.
![]() Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | 3 Jahre |
David Kabakoff | M | 76 | - | |
Bernhard E. Spiess | M | 64 | 5 Jahre | |
Patrick Hall | M | - | - | |
Joseph Cook | M | 53 | 3 Jahre | |
Mara Aspinall | F | 61 | 9 Jahre | |
Bonnie Anderson | F | 66 | 5 Jahre | |
Paul S. Manierre | M | 70 |
Encysive Pharmaceuticals, Inc.
![]() Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | 6 Jahre |
Garheng Kong | M | 49 | 3 Jahre | |
Frank Charles Carlucci | M | 91 |
Encysive Pharmaceuticals, Inc.
![]() Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | - |
William Ringo | M | 78 |
Encysive Pharmaceuticals, Inc.
![]() Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | 6 Jahre |
Carl Sterritt | M | 55 |
Encysive Pharmaceuticals, Inc.
![]() Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | - |
Timothy Decker | M | - | - | |
Federico A. Monzon | M | 56 | 5 Jahre | |
James L. Dunn | M | 62 | 2 Jahre | |
Elizabeth Ann Fagan | M | 74 |
Encysive Pharmaceuticals, Inc.
![]() Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | 2 Jahre |
Acosta Greg | M | - | 1 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 37 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Tobin Juvenal
- Persönliches Netzwerk